Quick Answer
Co-Diagnostics, Inc. reported Total Revenue of $622.5 thousand for fiscal year 2025.
Co-Diagnostics, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $622.5K | -84.1% |
| 2024 | $3.92M | -42.5% |
| 2023 | $6.81M | -80.1% |
| 2022 | $34.22M | -65.0% |
| 2021 | $97.89M | +31.3% |
| 2020 | $74.55M | +34579.9% |
| 2019 | $215.0K | +438.6% |
| 2018 | $39.9K | +420.9% |
| 2017 | $7.7K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $145.4K | -77.3% | -10.8% |
| June 30, 2025 | $162.9K | -93.9% | +224.0% |
| March 31, 2025 | $50.3K | -89.3% | -92.2% |
| September 30, 2024 | $641.1K | -73.9% | -75.9% |
| June 30, 2024 | $2.66M | +1243.2% | +467.9% |
| March 31, 2024 | $467.9K | -22.3% | -81.0% |
| September 30, 2023 | $2.46M | -51.8% | +1142.2% |
| June 30, 2023 | $197.8K | -96.1% | -67.1% |
- Co-Diagnostics, Inc. showed a decrease of -84.1% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2025 period, Co-Diagnostics, Inc.’s total revenue has grown by 8024.4% (from $7.7 thousand to $622.5 thousand).
- The most recent figure is from Co-Diagnostics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: